JENSCARE-B (09877) Sets 26 Mar 2026 Board Meeting to Approve FY 2025 Results and Discuss Final Dividend

Bulletin Express
03/16

Jenscare Scientific Co., Ltd. (JENSCARE-B, 09877) has announced that its board of directors will convene on Thursday, 26 March 2026. The session’s agenda includes:

• Reviewing and approving the consolidated financial results for the year ended 31 December 2025. • Considering a recommendation for the payment of a final dividend, if any. • Addressing other routine corporate matters.

The notice was issued by Executive Director and Chief Executive Officer Mr. Pan Fei on 16 March 2026. As of the announcement date, the board comprises one executive director, five non-executive directors and three independent non-executive directors.

免责声明:投资有风险,本文并非投资建议,以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请,作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考,不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证,投资者应自行研究并在投资前寻求专业建议。

热议股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10